Travere Therapeutics Stock Technical Analysis
| TVTX Stock | USD 22.91 0.81 3.41% |
As of the 17th of February 2025, Travere Therapeutics has the Coefficient Of Variation of 1243.22, risk adjusted performance of 0.0649, and Semi Deviation of 2.33. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Travere Therapeutics, as well as the relationship between them.
Travere Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Travere, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to TravereTravere |
Travere Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 27.4 | Strong Buy | 15 | Odds |
Most Travere analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Travere stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Travere Therapeutics, talking to its executives and customers, or listening to Travere conference calls.
Travere Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Travere Therapeutics Technical Analysis
The output start index for this execution was twenty-one with a total number of output elements of fourty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Travere Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Travere Therapeutics Trend Analysis
Use this graph to draw trend lines for Travere Therapeutics. You can use it to identify possible trend reversals for Travere Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Travere Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Travere Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Travere Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.08 , which means Travere Therapeutics will continue generating value for investors. It has 122 observation points and a regression sum of squares at 215.68, which is the sum of squared deviations for the predicted Travere Therapeutics price change compared to its average price change.About Travere Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Travere Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Travere Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Travere Therapeutics price pattern first instead of the macroeconomic environment surrounding Travere Therapeutics. By analyzing Travere Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Travere Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Travere Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2022 | 2023 | 2024 | 2025 (projected) | Payables Turnover | 0.44 | 0.27 | 0.25 | 0.3 | Days Of Inventory On Hand | 332.79 | 299.97 | 344.96 | 437.62 |
Travere Therapeutics February 17, 2025 Technical Indicators
Most technical analysis of Travere help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Travere from various momentum indicators to cycle indicators. When you analyze Travere charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0649 | |||
| Market Risk Adjusted Performance | 0.1591 | |||
| Mean Deviation | 2.48 | |||
| Semi Deviation | 2.33 | |||
| Downside Deviation | 2.54 | |||
| Coefficient Of Variation | 1243.22 | |||
| Standard Deviation | 3.39 | |||
| Variance | 11.52 | |||
| Information Ratio | 0.0772 | |||
| Jensen Alpha | 0.2611 | |||
| Total Risk Alpha | 0.2577 | |||
| Sortino Ratio | 0.1031 | |||
| Treynor Ratio | 0.1491 | |||
| Maximum Drawdown | 17.07 | |||
| Value At Risk | (4.12) | |||
| Potential Upside | 5.93 | |||
| Downside Variance | 6.45 | |||
| Semi Variance | 5.41 | |||
| Expected Short fall | (3.54) | |||
| Skewness | 0.9318 | |||
| Kurtosis | 2.19 |
Additional Tools for Travere Stock Analysis
When running Travere Therapeutics' price analysis, check to measure Travere Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Travere Therapeutics is operating at the current time. Most of Travere Therapeutics' value examination focuses on studying past and present price action to predict the probability of Travere Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Travere Therapeutics' price. Additionally, you may evaluate how the addition of Travere Therapeutics to your portfolios can decrease your overall portfolio volatility.